Form 4: Avanos Medical SVP Mojirade James Reports Stock Transaction

A Form 4 filing reveals that Mojirade James, SVP and General Counsel of Avanos Medical, Inc., surrendered shares to cover tax obligations upon vesting of restricted stock units.

Summary

• On July 22, 2024, Mojirade James, SVP and General Counsel of Avanos Medical, Inc., engaged in a transaction involving Avanos Medical's common stock.
• James surrendered 684 shares to the issuer to satisfy tax withholding obligations.
• The shares were surrendered at a price of $21.99 per share.
• This transaction occurred due to the vesting of time-based restricted share units (TRSUs) awarded on July 20, 2021.
• Following the transaction, James directly owns 70,313 shares of Avanos Medical common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously awarded stock-based compensation and the subsequent tax obligations.

Stakeholder Impact

• The transaction has a minor impact on the total number of outstanding shares, but is unlikely to significantly affect shareholders.

Key Dates